A drug that can prolong the lives of patients with advanced liver cancer has been rejected for use in the NHS in England, Wales and Northern Ireland.Quality care for all. Wait a minute! You there! Not you.
The market does it better, in concert with personal human caring.
No comments:
Post a Comment
Please remain on topic and keep coarse language to an absolute minimum. Comments in a language other than English will be assumed off topic.